Thermo Fisher Scientific's smaller rivals will soon get the chance to test their theory that focus can challenge diversity.

When Thermo and Fisher merge at the end of the year, they will create a life sciences behemoth with $9 billion in annual revenues, 7,500 sales people, and 350,000 customers worldwide. The $10.6 billion deal is the biggest in the life-science tool segment on record; the next-biggest in size is GE Healthcare's $9.5 billion acquisition of Amersham in 2004.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Magdalena Skipper, the incoming editor-in-chief of Nature, speaks with NPR's Weekend Edition Sunday.

Genetic genealogy has led to an arrest in another cold case, dating back to 1987.

In PLOS this week: mutation in second gene widens clinical symptoms of people with ADD3 mutations, comparative genomic analysis of Pseudovibrio, and more.

Wired reports that 23andMe is trying to bolster its outside collaborations.